PG

170.18

+1.73%↑

PM

154.22

+1.59%↑

PEP

153.57

+3.1%↑

MO

55

+1.23%↑

MDLZ

64.73

+4.2%↑

PG

170.18

+1.73%↑

PM

154.22

+1.59%↑

PEP

153.57

+3.1%↑

MO

55

+1.23%↑

MDLZ

64.73

+4.2%↑

PG

170.18

+1.73%↑

PM

154.22

+1.59%↑

PEP

153.57

+3.1%↑

MO

55

+1.23%↑

MDLZ

64.73

+4.2%↑

PG

170.18

+1.73%↑

PM

154.22

+1.59%↑

PEP

153.57

+3.1%↑

MO

55

+1.23%↑

MDLZ

64.73

+4.2%↑

PG

170.18

+1.73%↑

PM

154.22

+1.59%↑

PEP

153.57

+3.1%↑

MO

55

+1.23%↑

MDLZ

64.73

+4.2%↑

Search

USANA Health Sciences Inc

Cerrado

31.81 -0.59

Resumen

Variación precio

24h

Actual

Mínimo

31.64

Máximo

31.99

Métricas clave

By Trading Economics

Ingresos

11M

Ventas

200M

P/B

Media del Sector

11.099

44.075

BPA

0.56

Margen de beneficio

5.298

Empleados

1,800

EBITDA

24M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+62.05 upside

Dividendos

By Dow Jones

Próximas Ganancias

25 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-312M

599M

Apertura anterior

32.4

Cierre anterior

31.81

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

USANA Health Sciences Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

22 feb 2025, 00:16 UTC

Acciones populares

Stocks to Watch: Alamos Gold, Booking Holdings

22 feb 2025, 16:33 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 15:15 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 14:32 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 13:49 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 feb 2025, 13:22 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

21 feb 2025, 23:22 UTC

Principales Noticias

DOGE Aide's IRS Access Won't Include Personal Information -- Update

21 feb 2025, 23:20 UTC

Ganancias

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

21 feb 2025, 22:34 UTC

Charlas de Mercado

L'Oréal Cuts Exposure to Chinese Market, Grows Emerging Markets -- Market Talk

21 feb 2025, 22:12 UTC

Principales Noticias

DOJ Investigates Medicare Billing Practices at UnitedHealth -- 2nd Update

21 feb 2025, 21:54 UTC

Principales Noticias

Why Is Warren Buffett Hoarding So Much Cash? -- 2nd Update

21 feb 2025, 21:51 UTC

Ganancias

Tesla Stock Falls. Recalls and Rivian Are in the News. -- Barrons.com

21 feb 2025, 21:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

21 feb 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

21 feb 2025, 21:50 UTC

Principales Noticias

DOGE Aide's IRS Access Won't Include Personal Information -- WSJ

21 feb 2025, 21:48 UTC

Charlas de Mercado
Ganancias

L'Oréal Tops Estée Lauder in Luxury U.S. Market, CEO Says -- Market Talk

21 feb 2025, 21:35 UTC

Charlas de Mercado

Bulk of U.S. Imports From Canada Used to Make U.S. Goods -- Market Talk

21 feb 2025, 21:28 UTC

Principales Noticias

Why Is Warren Buffett Hoarding So Much Cash? -- Update

21 feb 2025, 21:24 UTC

Principales Noticias

Major U.S. Stock Indexes Give Up Gains From the Week -- WSJ

21 feb 2025, 21:19 UTC

Charlas de Mercado

Mexico's Inflation Seen Up in Early February -- Market Talk

21 feb 2025, 20:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

21 feb 2025, 20:15 UTC

Charlas de Mercado

JPMorgan Chase Branch Expansion Portends Deposit Growth -- Market Talk

21 feb 2025, 20:05 UTC

Charlas de Mercado

Oil Futures Retreat Into the Weekend Again -- Market Talk

21 feb 2025, 19:58 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Third Straight Weekly Gain -- Market Talk

21 feb 2025, 19:29 UTC

Charlas de Mercado

Gold Slides After Finding Record High -- Market Talk

21 feb 2025, 19:26 UTC

Principales Noticias

Major U.S. Stock Indexes Slip; UnitedHealth Pulls Down DJIA -- WSJ

21 feb 2025, 19:05 UTC

Charlas de Mercado

Business Conditions Seen as Favoring Corporate Credit -- Market Talk

21 feb 2025, 19:02 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

21 feb 2025, 19:02 UTC

Charlas de Mercado

Corporate Credit Expected to Be Hit Unevenly by Trade Wars -- Market Talk

21 feb 2025, 19:00 UTC

Charlas de Mercado

Long-Term Treasury Yields Expected to Rise -- Market Talk

Comparación entre iguales

Cambio de precio

USANA Health Sciences Inc Esperado

Precio Objetivo

By TipRanks

62.05% repunte

Estimación a 12 meses

Media 51.5 USD  62.05%

Máximo 65 USD

Mínimo 38 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para USANA Health Sciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

2 ratings

0

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

31.21 / 31.88Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de USANA Health Sciences Inc

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.